FOXM1 and hepatocellular carcinoma: Taken together, the above data indicated that FOXM1 was upregulated in approximately 40% of HCC cases with serum AFP elevation and poor survival outcome, and its overexpression was strongly correlated with the activation of stem cell markers and the mitotic cell cycle and the inactivation of mature hepatocyte metabolism function.